CorMedix

$3.20 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About CorMedix

CorMedix Inc. is a biopharmaceutical company. The Company develops and commercialize therapeutic products for the treatment of cardiac, renal, infectious, and inflammatory diseases. CorMedix serves patients in the United States.

Stock Analysis

last close $3.2
1-mo return -23.4%
3-mo return 3.9%
avg daily vol. 663.6T
52-week high 8.03
52-week low 2.65
market cap. $279M
forward pe -
annual div. -
roe -40%
ltg forecast -
dividend yield -
annual rev. $0M
inst own. 34.6%
baraka

Subscribe now for daily local and international financial news

Subscribe